Northpond Ventures — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Aro is a Brazilian technology platform that connects users with over 40 regulated credit partners to find personal loans, payroll (consignado CLT) loans, phone-collateral loans, and credit for people with negative credit records.
AI & Machine LearningB2B MarketplacesFintech
Co-investorsNorte Ventures17SigmaCowen Healthcare InvestmentsOnevc Venture Partners Llc
Aro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins.
BiotechHealthtechPhiladelphia, US
Karyn O'Neil(Executive Officer, Director)Susan Dillon(Founder)inMark V. Laurenzi(Executive Officer)
BoardElizabeth Anderson(Director)Bruce Peacock(Director)
Co-investorsAvego BioScience CapitalHealthCapAgent CapitalBiotechnology Value FundCowen Healthcare InvestmentsJohnson & Johnson Innovation – JJDC
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Bot-It
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.